suggested that these drugs act at the same receptor sites as dihydropyridines (11). In our studies, the diphenylalkylamines prenylamine, flunarizine, and lidoflazine and the phenylailylamine tiapamil maximally inhibit [3HInitrendipine. binding (Fig. 1) (Fig. 2) . As previously reported (9), verapamil speeds the dissociation of
Several distinct classes of organic calcium antagonist drugs are important therapeutic agents in cardiovascular and numerous other medical conditions (1, 2) . At least four classes ofstructures are distinguished: the dihydropyridines exemplified by nifedipine (1) (2) (3) , phenylalkylamines exemplified by verapamil (1) (2) (3) , benzothiazepines such as diltiazem (1, 2, 4) , and diphenylalkylamines such as prenylamine and lidoflazine (1, -2, 5). Receptors for the drugs are labeled with [3H]nitrendipine (6) (7) (8) (9) (10) , or [3H]nimodipine (10) and regulated in a physiological fashion by calcium (7) . The apparent competitive inhibition of [3H]nitrendipine binding by diphenylalkylamines has implied effects at the same site as the dihydropyridines (11) . Verapamil and diltiazem respectively inhibit and stimulate [3H]nitrendipine binding allosterically, suggesting actions at different sites (9, 12) . Here we show that the phenylalkylamine, diphenylalkylamine, and benzothiazepine drugs, -in pharmacologically relevant concentrations, interact.at a single drug recognition site allosterically linked to the dihydropyridine receptor. We predict and confirm by bioassay previously unknown calcium antagonist activity for several drugs.
MATERILS AND METHODS
Drugs were obtained from the following sources: nifedipine, Pfizer; nimodipine, Miles; prenylamine, Hoechst-Roussel Pharmaceuticals (Somerville, NJ); D-600 (gallopamil, methoxyverapamil) and verapamil, Knoll Pharmaceutical (Whippany, NJ); diltiazem, Marion Laboratories (Kansas City, MO) and Tanabe (Osaka, Japan); desmethyl-cis-diltiazem and -trans-diltiazem, Tanabe; lidoflazine, flunarizine, and cinnarizine, Janssen Pharmaceutical (Beerse, Belgium); and bepridil, McNeil Pharmaceutical (Spring House, PA). Binding assays in guinea pig brain membranes, filtration, and liquid scintillation counting were carried out as described (7) . All experiments, performed in triplicate, were replicated at least three times with similar results. Guinea pig ileum longitudinal muscles were prepared for recording as described by Rosenberger et aL (13) and incubated in a modified Tyrode's buffer (14) at 370C with continuous aeration with 95% '02/5% CO2. Ileum longitudinal muscles were incubated in this buffer for 30 min before Ca2"-dependent contractions were recorded as described by Jim et aL (15 (9) . Because diphenylalkylamines inhibit [3H]-nitrendipine binding completely, it was suggested that these drugs act at the same receptor sites as dihydropyridines (11) . In our studies, the diphenylalkylamines prenylamine, flunarizine, and lidoflazine and the phenylailylamine tiapamil maximally inhibit [3HInitrendipine. binding (Fig. 1) (Fig. 2) . As previously reported (9) 20-30%) (Fig. 3) should block the ability of a diphenylalkylamine to inhibit [3H]nitrendipine binding, with a rightward shift in concentration-response curves. Indeed, increasing concentrations of D-600 do produce rightward shifts in the concentration-response curves for inhibition of [3H]nitrendipine binding by the diphenylalkylamines prenylamine, flunarizine, and lidoflazine ( Fig. 1 a-c) . Tiapamil, a phenylalkylamine closely similar in structure to verapamil and D-600 (16) 
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Whereas diphenylalkylamines and phenylalkylamines inhibit [3H]nitrendipine binding, diltiazem stimulates binding when evaluated in the absence ofother drugs (Fig. 4a) (12, 17) . It has been suggested that diltiazem. therefore acts at a distinct site, specific for benzothiazepines, and different from the site at which the phenylalkylamines and diphenylalkylamines act (12, 17) . If this were the case, no direct interactions should occur between the benzothiazepines and the phenylalkylamines or diphenylalkylamines. To evaluate possible interactions, we explored the effect ofdiltiazenmon.
[3H]nitrendipine binding in the presence of D-600, prenylamine, and tiapamil (Fig. 4a) . Dil .
-log |dl~tjazeml (M) whereas the other drugs decrease this affinity. To ascertain whether this effect of diltiazem is related to the pharmacologic actions of the drug, we compared cis-and transdiltiazem, because only the cis isomer has pharmacological efficacy. We also evaluated desmethyl-cis-diltiazem, which pharmacologically is about 30-50% as potent as diltiazem (4) . En AuM tiapamil is elicited by cis-but not trans-diltiazem (Fig. 4b) .
Desmethyl-cis-diltiazem is only about half as potent as cis-diltiazem. These relative activities are consistent with interactions at the pharmacologically relevant site of action of diltiazem. Reduction of [3H]nitrendipine binding at high concentrations of cis-diltiazem occurs similarly with trans-diltiazem and desmethyl-cis-diltiazem, indicating no pharmacologic relevance (Fig. 4b) .
The phenylalkylamines and diphenylalkylamines possess two widely separated aromatic domains with the amine located centrally, whereas diltiazem possesses only one aromatic domain linked to an alkylamine moiety. We predicted that some drugs with one aromatic domain and an alkylamine moiety might interact with receptors as diltiazem does. We have found that the H1 antihistamines dimethindene and chlorpheniramine, the muscarinic anticholinergic biperiden, the neuroleptics mesoridazine and thioridazine, and the organic calcium antagonist bepridil (18) all display the diltiazem-like.action of enhancing [3H] nitrendipine binding (Fig. 5) .
Dimethindene not only enhances [3H]nitrendipine binding in the absence of other drugs but, like diltiazem, it reverses the inhibition of [3H]nitrendipine binding elicited by D-600, prenylamine, and tiapamil (Fig. Sa) . Bepridil, thioridazine, biperiden, chlorpheniramine, and mesoridazine overcome the inhibition caused by 2.5 ,uM tiapamil, enhancing [3H]nitrendipine binding from 10% to 80% of control (Fig. 5b) . Bepridil, thioridazine, and biperiden show biphasic effects like diltiazem, causing an inhibition of [3H]nitrendipine binding at higher concentrations.
To determine whether these effects on binding validly predict pharmacologic calcium channel antagonism, we explored the actions of these drugs on guinea pig ileum contractions (Fig.   6 ). The Schild plot for dimethindene inhibition of Ca2"-dependent contractions shows a pA2 of 4.95 (Fig. 6 ), similar to dimethindene's potency in stimulating [3H]nitrendipine binding. Furthermore, 25 uM -thioridazine, biperiden, chlorpheniramine, and mesoridazine inhibit Ca2+-dependent contractions of guinea pig ileal muscle by 97%, 95%, 66%, and 51%, re- spectively. This order of potency corresponds to the drugs' potencies in enhancing [3H]nitrendipine binding (Fig. 5b) . 6 . Dimethindene blocks calcium-dependent contractions of KCl-depolarized guinea pig ileum. Concentration-response curves for the calcium-dependent contractions of the guinea pig ileum in the absence or the presence of various concentrations of dimethindene were constructed by sequential additions of calcium chloride to a calcium-free high-potassium buffer. Only one dimethindene concentration was employed in any tissue. log(dose ratio -1) is plotted against log[dimethindene] and the pA2 (4.95) was determined by linear regression (r = 0.97). pA2 is the negative logarithm of the concentration at which the dose ratio is 2; it is equivalent to -log app. Dose ratio is the ratio of agonist, in the absence and presence of antagonist, which gives the same response. calcium ion channels by drugs (Fig. 7) 
